Interplay of non-coding RNAs and approved antimetabolites such as gemcitabine and pemetrexed in mesothelioma.
Noncoding RNA Res
; 3(4): 213-225, 2018 Dec.
Article
en En
| MEDLINE
| ID: mdl-30809600
AKBA, 3-acetyl-11-keto-ß-boswellic acid; Anticancer drugs; Bcl-2, B-cell lymphoma 2; DADS, diallyl sulfide; DHA, docosahexaenoic acid; DIM, 3,3'-diindolylmethane; DMPM, diffuse malignant peritoneal mesothelioma; EGCG, epigallocatechin-3-gallate; EMT, epithelial-mesenchymal transition; Gemcitabine; HOTAIR, HOX transcript antisense RNA; I3C, indole-3-carbinol; Long non-coding RNA; MALAT1, metastasis-associated lung adenocarcinoma transcript 1; MPM, malignant pleural mesothelioma; Mesothelioma; MicroRNA; NSCLC, non-small cell lung cancer; NaB, sodium butyrate; PDCD4, programmed cell death 4; PEG, polyethylene glycole; PEITC, phenethylisothiocyanate; PTEN, phosphatase and tensin homolog; Pemetrexed; RA, retinoic acid; SAHA, suberoylanilide hydroxamic acid; SFN, sulforaphane; TSA, trichostatin A
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Idioma:
En
Revista:
Noncoding RNA Res
Año:
2018
Tipo del documento:
Article
País de afiliación:
Alemania